NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • About Patient and Public Involvement
      • Our Work with Patients and the Public
      • Learn More About Our Research
      • Patient Involvement Blog
      • External Links
    • For Patients, Carers and the Public
      • Current Listings for Involvement
      • REGISTER INTEREST
      • Patient and Public Involvement Workshops
    • PPI Resources for Researchers
      • PPI Strategy
      • A Researcher’s Guide to PPI
      • PPI Resources for Researchers
      • PPI Briefing Notes
      • PPI Case Studies
      • PPI Advisory Group
      • PPI Events for Researchers
      • Post a PPI Listing
      • Public Engagement for Researchers
      • Public Engagement Case Studies
  • Training Hub
    • Training Hub
    • Fellowships
    • Funding Opportunities
    • Clinical Researchers and Scientists
    • Nurses, Midwives and Allied Health Professionals
    • Next Generation Leaders Programme
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > COVID-19 > Oxford study shows high level of readmissions and death after COVID-19 discharge

Oxford study shows high level of readmissions and death after COVID-19 discharge

22 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19

Some 30% of patients discharged after being admitted to hospital with community-acquired COVID-19 had been readmitted or died within 60 days, a study by Oxford researchers has shown.

In a paper published in the European Journal of Public Health, they found that, as anticipated, rates of readmission or death were higher among older adults. However, rates were twice as high among women than men, in contrast with studies of in-hospital mortality and morbidity for COVID-19, which have tended to find that men had higher rates of admission to critical care or death than women.

The study, which looked at electronic patient data from Oxford University Hospitals (OUH) NHS Foundation Trust as part of the National Institute of Health Research (NIHR) Health Informatics Collaborative, was carried out by researchers from the University of Oxford and OUH, with support from the NIHR Oxford Biomedical Research Centre (BRC).

The study’s lead author, Dr Nazrul Islam, of the University of Oxford’s Big Data Institute and Nuffield Department of Population Health, said: “We believe this is the first study to describe clinically meaningful variations by demographic factors in longer-term outcomes among patients admitted with community-acquired COVID-19 in the UK.

“Previous studies have focused mainly on survival during hospitalisation and data on patients discharged following hospitalisation for COVID-19 have been scarce.” Dr Islam is now leading a World Health Organisation study looking at COVID-19 mortality demographics worldwide.

Senior author Dr Ben Lacey said: “One of the main findings from the first wave in the UK was that men are more likely to have severe outcomes, including ventilation and death. It is only now, however, that we are getting a clear picture of the effects among survivors from COVID-19 hospitalisations. It’s important to recognise that just because people are surviving their first admission, that doesn’t mean it’s the end of the story.”

National studies have now been initiated to understand the high rates of readmission or death following COVID-19 discharge in the UK, and to assess what can be done to prevent the adverse long-term effects of COVID-19.

Another author on the paper, Prof Jim Davies of the Big Data Institute and the NIHR Oxford BRC’s Co-theme Lead for Clinical Informatics, said: “This study is another example of how Oxford is utilising the rich supply of NHS data at its disposal and increasing our understanding of the pandemic, identifying important trends and allowing us to develop strategies to tackle them.”

← Oxford-led technology to help those at high risk from Covid-19
Oxford study reveals public attitudes to vaccine roll-out programmes →

News

  • Oxford academics named NIHR Senior Investigators 3 March 2021
  • New centre aims to help companies conduct more efficient trials 26 February 2021
  • Oxford study reveals public attitudes to vaccine roll-out programmes 23 February 2021
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2021 NIHR Oxford Biomedical Research Centre

Cookies

This site uses cookies See our data control and privacy page